Rubius Therapeutics Earnings Preview


Rubius Therapeutics RUBY is set to give its latest quarterly earnings report on Friday, 2022-02-25. Here's what investors need to know before the announcement.

Analysts estimate that Rubius Therapeutics will report an earnings per share (EPS) of $-0.59.

Rubius Therapeutics bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company beat EPS by $0.02, which was followed by a 3.59% increase in the share price the next day.

Here's a look at Rubius Therapeutics's past performance and the resulting price change:

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -0.57 -0.49 -0.52 -0.49
EPS Actual -0.55 -0.56 -0.51 -0.50
Price Change % 3.59% 3.03% 1.16% -1.41%

Stock Performance

Shares of Rubius Therapeutics were trading at $4.57 as of February 23. Over the last 52-week period, shares are down 56.17%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

To track all upcoming earnings announcements, click here to use Benzinga Earnings Calendar.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-EP
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!